Interstitial pneumonia during bevacizumab-based chemotherapy for colorectal cancer

Medical Oncology

Volumn 31, Issue 3, 2014, Pages

  Tamura, Shingo ^a   Kusaba, Hitoshi ^a   Kubo, Naoki ^a   Ijichi, Kayo ^a   Tsuchihashi, Kenji ^a   Komoda, Masato ^a   Uchino, Keita ^b   Ariyama, Hiroshi ^a   Akashi, Koichi ^a   Baba, Eishi ^c  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Bevacizumab; Chemotherapy; Colorectal cancer; Interstitial pneumonia; Molecular targeting agent

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; METHYLPREDNISOLONE; OXALIPLATIN; PREDNISOLONE; RABEPRAZOLE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; MONOCLONAL ANTIBODY; PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COLORECTAL CANCER; CORTICOSTEROID THERAPY; CRACKLE; DIARRHEA; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPNEA; EARLY DIAGNOSIS; FEMALE; GENERAL CONDITION IMPROVEMENT; HEMATOLOGIC DISEASE; HUMAN; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; SMOKING; SYSTEMIC THERAPY; TREATMENT OUTCOME; CANCER STAGING; CHEMICALLY INDUCED DISORDER; COLORECTAL TUMOR; FOLLOW UP; INTERSTITIAL LUNG DISEASE; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; THORAX RADIOGRAPHY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PREDNISOLONE; PROGNOSIS; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES;

EID: 84892936571     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0856-0     Document Type: Article

References (11)

1. Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol. 2007;25:1539-44.
2. Welch S, Spithoff K, Rumble RB, Maroun J. Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review. Ann Oncol. 2010;21:1152-62.
3. Prat A, Martínez P, Serrano C, Montero MA, Andreu J, Cortés J. Acute lung injury associated with docetaxel and bevacizumab. Clin Oncol. 2007;19:803-5.
4. Tamura J, Nakauchi M, Nakayama Y, Kitaguchi K, Sakikubo M, Ura K, et al. A case of interstitial pneumonitis induced by FOLFIRI+ bevacizumab combination therapy for liver and lung metastasis of colon cancer (in Japanese). Gan To Kagaku Ryoho. 2009;36:2665-8.
5. Nakagawa M, Hamada A, Yoshihara Y, Ishizaka T, Fukushima M, Takahashi N, et al. A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) (in Japanese). Gan To Kagaku Ryoho. 2011;38:317-20.
6. Huobera J, Schochb O, Templetona A, Spiriga C, Thurlimann B. Interstitial pneumonitis after treatment with bevacizumab and pegylated liposomal doxorubicin in a patient with metastatic breast cancer. Chemotherapy. 2010;56:69-70.
7. Usui K, Katou Y, Furushima K, Tanaka Y, Tanai C, Ishihara T. Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patients. Jpn J Clin Oncol. 2011;41:498-502.
8. Kudoh S, Kato H, Nishiwaki Y, Fukuoka M, Nakata K, et al. Interstitial lung disease in Japanese patients with lung cancer. Am J Respir Crit Care Med. 2008;177:1348-57.
9. Ferrara N. VEGF as a therapeutic target in cancer. Oncology. 2005;69:11-6.
10. Simler NR, Brenchley PE, Horrocks AW, Greaves SM, Hasleton PS, Egan JJ. Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax. 2004;59:581.
11. Thickett DR, Armstrong L, Millar AB. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med. 2002;166:1332-7.